Akari Therapeutics, Plc
USD10.39
-0.27 (-2.53%)
CEO
Abizer Gaslightwala
IPO Date
2014-01-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.49
Prev. Close
$10.66
Day Low
$10.39
Day High
$11.59
52W Low
$3.02
52W High
$49.60
Market Cap
$0.01B
Volume
0.01M
| 15,466 |
| $0.00 |
| 17 Jul 2026 | Patel Samir Rashmikant | director, 10 percent owner: | M-Exempt | Acquired | 5,799 | $0.00 |
| 17 Jul 2026 | Patel Samir Rashmikant | director, 10 percent owner: | M-Exempt | Acquired | 1,209 | $8.00 |
| 17 Jul 2026 | Patel Samir Rashmikant | director, 10 percent owner: | M-Exempt | Acquired | 5,799 | $0.00 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 1,248 | $10.02 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 1,395 | $9.32 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 1,570 | $8.28 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 2,539 | $5.12 |
| 25 Jun 2026 | Farag Kameel D. | Interim CFO | A-Award | Acquired | 3,725 | $3.49 |